iShares Biotechnology ETF (NASDAQ:IBB) Shares Sold by PNC Financial Services Group Inc.

PNC Financial Services Group Inc. reduced its holdings in iShares Biotechnology ETF (NASDAQ:IBB) by 2.8% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 358,192 shares of the financial services provider’s stock after selling 10,473 shares during the period. PNC Financial Services Group Inc. owned about 0.71% of iShares Biotechnology ETF worth $52,153,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also recently made changes to their positions in IBB. Edgestream Partners L.P. acquired a new stake in iShares Biotechnology ETF during the first quarter valued at $436,000. O Shaughnessy Asset Management LLC boosted its stake in shares of iShares Biotechnology ETF by 19.5% during the 1st quarter. O Shaughnessy Asset Management LLC now owns 1,986 shares of the financial services provider’s stock worth $273,000 after acquiring an additional 324 shares in the last quarter. EP Wealth Advisors LLC grew its position in shares of iShares Biotechnology ETF by 6.7% during the 1st quarter. EP Wealth Advisors LLC now owns 9,921 shares of the financial services provider’s stock valued at $1,361,000 after acquiring an additional 619 shares during the period. Alpine Global Management LLC purchased a new position in shares of iShares Biotechnology ETF in the 1st quarter valued at about $1,759,000. Finally, Flow Traders U.S. LLC increased its stake in shares of iShares Biotechnology ETF by 873.2% in the 1st quarter. Flow Traders U.S. LLC now owns 22,802 shares of the financial services provider’s stock valued at $3,129,000 after purchasing an additional 20,459 shares in the last quarter. Institutional investors and hedge funds own 62.45% of the company’s stock.

iShares Biotechnology ETF Price Performance

Shares of IBB opened at $134.84 on Thursday. iShares Biotechnology ETF has a 12 month low of $117.28 and a 12 month high of $150.57. The stock’s 50 day moving average is $143.82 and its two-hundred day moving average is $141.75.

iShares Biotechnology ETF Dividend Announcement

The firm also recently announced a dividend, which was paid on Monday, September 30th. Shareholders of record on Wednesday, September 25th were paid a dividend of $0.2005 per share. The ex-dividend date was Wednesday, September 25th.

iShares Biotechnology ETF Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.